Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency

被引:2
|
作者
Liongue, Clifford [1 ,2 ]
Ratnayake, Tarindhi [1 ]
Basheer, Faiza [1 ,2 ]
Ward, Alister C. [1 ,2 ]
机构
[1] Deakin Univ, Sch Med, Geelong, Vic 3216, Australia
[2] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat IMPACT, Geelong, Vic 3216, Australia
关键词
cytokine; cytokine receptor; immunity; immunodeficiency; JAK3; leukemia; ACUTE MEGAKARYOBLASTIC LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; STAT PATHWAY; STEM-CELL; ACTIVATING MUTATIONS; DEFICIENCY; RECEPTOR; CYTOKINE; INTERLEUKIN-2; FAMILY;
D O I
10.3390/ijms25052977
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Janus kinase (JAK) family is a small group of protein tyrosine kinases that represent a central component of intracellular signaling downstream from a myriad of cytokine receptors. The JAK3 family member performs a particularly important role in facilitating signal transduction for a key set of cytokine receptors that are essential for immune cell development and function. Mutations that impact JAK3 activity have been identified in a number of human diseases, including somatic gain-of-function (GOF) mutations associated with immune cell malignancies and germline loss-of-function (LOF) mutations associated with immunodeficiency. The structure, function and impacts of both GOF and LOF mutations of JAK3 are highly conserved, making animal models highly informative. This review details the biology of JAK3 and the impact of its perturbation in immune cell-related diseases, including relevant animal studies.
引用
收藏
页数:13
相关论文
共 37 条
  • [31] A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response
    Liu, Ke
    Kunii, Naoko
    Sakuma, Megumi
    Yamaki, Atsumi
    Mizuno, Satoru
    Sato, Mayu
    Sakai, Hiromichi
    Kado, Sayaka
    Kumagai, Kazuo
    Kojima, Hirotatsu
    Okabe, Takayoshi
    Nagano, Tetsuo
    Shirai, Yasuhito
    Sakane, Fumio
    JOURNAL OF LIPID RESEARCH, 2016, 57 (03) : 368 - 379
  • [32] A case of aberrant CD8 T cell-restricted IL-7 signaling with a Janus kinase 3 defect-associated atypical severe combined immunodeficiency
    Khanolkar, Aaruni
    Wilks, Jeffrey D.
    Liu, Guorong
    Simpson, Bridget M.
    Caparelli, Edward A.
    Kirschmann, Dawn A.
    Bergerson, Jenna
    Fuleihan, Ramsay L.
    IMMUNOLOGIC RESEARCH, 2020, 68 (01) : 13 - 27
  • [33] miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction
    Margherita Gigante
    Paola Pontrelli
    Wolfgang Herr
    Maddalena Gigante
    Morena D’Avenia
    Gianluigi Zaza
    Elisabetta Cavalcanti
    Matteo Accetturo
    Giuseppe Lucarelli
    Giuseppe Carrieri
    Michele Battaglia
    Walter J. Storkus
    Loreto Gesualdo
    Elena Ranieri
    Journal of Translational Medicine, 14
  • [34] miR-29b and miR-198 overexpression in CD8+ T cells of renal cell carcinoma patients down-modulates JAK3 and MCL-1 leading to immune dysfunction
    Gigante, Margherita
    Pontrelli, Paola
    Herr, Wolfgang
    Gigante, Maddalena
    D'Avenia, Morena
    Zaza, Gianluigi
    Cavalcanti, Elisabetta
    Accetturo, Matteo
    Lucarelli, Giuseppe
    Carrieri, Giuseppe
    Battaglia, Michele
    Storkus, Walter J.
    Gesualdo, Loreto
    Ranieri, Elena
    JOURNAL OF TRANSLATIONAL MEDICINE, 2016, 14
  • [35] Modulation of CD8+ memory stem T cell activity and glycogen synthase kinase 3β inhibition enhances anti-tumoral immunity in gastric cancer
    Zhang, Jin-yu
    Zhao, Yong-liang
    Lv, Yi-pin
    Cheng, Ping
    Chen, Weisan
    Duan, Mubin
    Teng, Yong-sheng
    Wang, Ting-ting
    Peng, Liu-sheng
    Mao, Fang-yuan
    Liu, Yu-gang
    Fu, Xiao-long
    Yu, Pei-wu
    Luo, Ping
    Zhang, Wei-jun
    Zou, Quan-ming
    Zhuang, Yuan
    ONCOIMMUNOLOGY, 2018, 7 (04):
  • [36] Mutations in genes required for T-cell development:: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency:: HuGE review
    Kalman, L
    Lindegren, ML
    Kobrynski, L
    Vogt, R
    Hannon, H
    Howard, JT
    Buckley, R
    GENETICS IN MEDICINE, 2004, 6 (01) : 16 - 26
  • [37] Small cell transformation in EGFR-mutated non-small cell lung cancer: DLL3 expression and efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with chemotherapy
    Saalfeld, Felix Carl
    Moeller, Johanna
    Christopoulos, Petros
    Wenzel, Carina
    Rasokatf, Anna
    Wangg, Xuejun Alice
    Vathiotish, Ioannis
    Koenigi, David
    Illinij, Oliver
    Grohe, Christian
    Wiesweg, Marcel
    Wesseler, Claas
    Schubart, Christoph
    Pelusi, Natalie
    Rohde, Gernot
    Overbeck, Tobias R.
    Kirfel, Jutta
    Alt, Juergen
    Kauffmann-Guerrero, Diego
    Griesingerv, Frank
    Kulhavyw, Jonas
    Allgaeuer, Michael
    Klimovay, Anna
    Schuetz, Maret
    Aust, Daniela E.
    Hochmairj, Maximilian J.
    Rothschild, Sacha I.
    Syrigos, Konstantinos N.
    Veluswamy, Rajwanth
    Michels, Sebastian
    Stenzinger, Albrecht
    Joehrens, Korinna
    Wermke, Martin
    EUROPEAN JOURNAL OF CANCER, 2024, 213